TABLE 1.
Studies and Receptors Studied
|
EC50
|
|||
---|---|---|---|---|
d-Amphetamine | l-Amphetamine | d-Methamphetamine | MDMA | |
μM | ||||
Bunzow et al. (2001); Reese et al. (2007) | ||||
mTAAR1 | 0.21 | 4.96 | 0.92 | |
rTAAR1 | 0.81 | 0.29 | 0.89 | 1.700[(±)-MDMA] |
h-rTAAR1 | 1.12 | 3.09 | 4.44 | |
Wolinsky et al. (2006) | ||||
mTAAR1 | 0.002 | 0.065 | 0.070 | |
Miller et al. (2005); Xie and Miller (2007); Xie et al. (2007) | ||||
rhTAAR1 | 0.682 | 1.700 | 0.320 | |
Wainscott et al. (2007) | ||||
rTAAR1 | 1.210 | 1.400 | ||
hTAAR1 | 0.994 | 1.720 | ||
Lewin et al. (2008) | ||||
hTAAR1 | 0.935 | 0.920 | ||
Barak et al. (2008) | ||||
hTAAR1 | 0.136 | 0.245 | 1.31 | 0.370[(+)-MDMA] |
mTAAR1, mouse TAAR1; rTAAR1, rat TAAR1; rhTAAR1, rhesus monkey TAAR1; h-rTAAR1, chimeric human-rat TAAR1; hTAAR1, human TAAR1